Explore Products

My Quote Request

No products added yet

6505-01-416-4017

20 Products

ZESTRIL TABLETS

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

View More Info

ZESTRIL TABLETS

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

MFG

ASTRAZENECA LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 20MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00185-0102-33

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

View More Info

NDC00185-0102-33

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

MFG

EON LABS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 20MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

View More Info

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164017

NSN

6505-01-416-4017

MFG

ASTRAZENECA LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 20MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

95-0414

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

View More Info

95-0414

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABSELTS USP 10MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00185-0101-33

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

View More Info

NDC00185-0101-33

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

MFG

CENTRAL SHARPENING CO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABSELTS USP 10MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

View More Info

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014164018

NSN

6505-01-416-4018

MFG

ASTRAZENECA LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABSELTS USP 10MG 3000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

95-0391

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505014164328

NSN

6505-01-416-4328

View More Info

95-0391

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505014164328

NSN

6505-01-416-4328

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION 10ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: 2 PCT DORZOLAMIDE EQUIVALENT

NDC00006-3519-36

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505014164328

NSN

6505-01-416-4328

View More Info

NDC00006-3519-36

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505014164328

NSN

6505-01-416-4328

MFG

DIXON-SHANE LLC DBA R & S NORTHEAST

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION 10ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: 2 PCT DORZOLAMIDE EQUIVALENT

95-0437

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

View More Info

95-0437

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

NDC00024-1352-02

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

View More Info

NDC00024-1352-02

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

NEO-SYNEPHRINE

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

View More Info

NEO-SYNEPHRINE

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

NEO-SYNEPHRINE EXTRA STRENGTH

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

View More Info

NEO-SYNEPHRINE EXTRA STRENGTH

PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP

NSN, MFG P/N

6505014165692

NSN

6505-01-416-5692

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

95-0404

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

View More Info

95-0404

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 180.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GANCICLOVIR CAPSULES 250MG 180S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 250 MG;STORE AT ROOM TEMP 59-86 DEG F

CYTOVENE

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

View More Info

CYTOVENE

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

MFG

SYNTEX LABORATORIES INC

Description

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 180.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GANCICLOVIR CAPSULES 250MG 180S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 250 MG;STORE AT ROOM TEMP 59-86 DEG F

NDC00004-0269-48

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

View More Info

NDC00004-0269-48

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

MFG

SYNTEX LABORATORIES INC

Description

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 180.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GANCICLOVIR CAPSULES 250MG 180S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 250 MG;STORE AT ROOM TEMP 59-86 DEG F

NDC00033-2913-50

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

View More Info

NDC00033-2913-50

GANCICLOVIR CAPSULES

NSN, MFG P/N

6505014168781

NSN

6505-01-416-8781

MFG

SYNTEX LABORATORIES INC

Description

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 180.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GANCICLOVIR CAPSULES 250MG 180S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 250 MG;STORE AT ROOM TEMP 59-86 DEG F

95-0446

GLOBULIN,RHO (D) IMMUNE,USP

NSN, MFG P/N

6505014171250

NSN

6505-01-417-1250

View More Info

95-0446

GLOBULIN,RHO (D) IMMUNE,USP

NSN, MFG P/N

6505014171250

NSN

6505-01-417-1250

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE USP 300MCG SYRINGE
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 300 MICROGRAMS; ADULT DOSE; DISPOSABLE; 1ML SYRINGE WITH SAFETY; INJECT ONLY INTRAMUSCULARLY; STORE AT 2-8 DEG.C; DO NOT FREEZE; DISPENSE BY PRESCRIPTION ONLY

NDC13533-0631-02

GLOBULIN,RHO (D) IMMUNE,USP

NSN, MFG P/N

6505014171250

NSN

6505-01-417-1250

View More Info

NDC13533-0631-02

GLOBULIN,RHO (D) IMMUNE,USP

NSN, MFG P/N

6505014171250

NSN

6505-01-417-1250

MFG

TALECRIS BIOTHERAPEUTICS INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE USP 300MCG SYRINGE
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 300 MICROGRAMS; ADULT DOSE; DISPOSABLE; 1ML SYRINGE WITH SAFETY; INJECT ONLY INTRAMUSCULARLY; STORE AT 2-8 DEG.C; DO NOT FREEZE; DISPENSE BY PRESCRIPTION ONLY

95-0392

SUCCINYLCHOLINE CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014171254

NSN

6505-01-417-1254

View More Info

95-0392

SUCCINYLCHOLINE CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014171254

NSN

6505-01-417-1254

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCCINYLCHOLINE CHLORIDE INJECTION USP 20MG/ML 10ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00409-6629-02

SUCCINYLCHOLINE CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014171254

NSN

6505-01-417-1254

View More Info

NDC00409-6629-02

SUCCINYLCHOLINE CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014171254

NSN

6505-01-417-1254

MFG

HOSPIRA INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCCINYLCHOLINE CHLORIDE INJECTION USP 20MG/ML 10ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25